AU · Healthcare

INVEX Therapeutics Ltd (IXC)

Biotechnology

INVEX Therapeutics Ltd (IXC) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IXC

P/E ratio

18.00

INVEX Therapeutics Ltd (IXC) — FAQ

What is IXC's P/E ratio?

The price-to-earnings (P/E) ratio for INVEX Therapeutics Ltd (IXC) is 18.00 (data as of 2026-03-23).

Does INVEX Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for INVEX Therapeutics Ltd (IXC). Check the MyAverix Finance app for the latest dividend data.

What sector is INVEX Therapeutics Ltd in?

INVEX Therapeutics Ltd (IXC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IXC listed on?

IXC is listed on AU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)